why choose us

First received: September 09, 2023

Clinical Trial: Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Moderate Plaque Psoriasis

Study Type: INTERVENTIONAL


Official Title: A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area (BSA) Moderate Pl

Brief Summary: The purpose of this study is to evaluate the efficacy of guselkumab compared to an inactive drug in participants with low body surface area moderate plaque psoriasis and special site involvement.

Read more